Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.
Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.
- This report provides in-depth analysis of the global drug abuse treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global drug abuse treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market.
-
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
-
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
-
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Cipla Limited
- Glenmark Pharmaceuticals
- Pfizer Inc.
- Mylan N.V.
- Odyssey Pharmaceuticals Inc.
- Lil' Drug Store Products Inc.
- Indivior Plc.
- Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- British American Tobacco Plc.
- Alkermes
- Sun Pharmaceuticals
- BioCorRx, Inc.
- DXC Technology Company
